INTERFERON: WESENTLICH VEREINFACHTE, ENZYM-IMMUNOLOGISCHE BESTIMMUNG MIT ZWEI MONOKLONALEN ANTIKOERPERN = INTERFERON: A GREATLY SIMPLIFIED, ENZYME-IMMUNOLOGICAL DETERMINATION, USING TWO MONOCLONAL ANTIBODIES = INTERFERON: DETERMINATION PAR LA METHODE IMMUNOENZYMATIQUE TRES SIMPLIFIEE A L'AIDE DE DEUX ANTICORPS MONOCLONAUXGALLATI H.1982; JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY; ISSN 0340-076X; DEU; DA. 1982; VOL. 20; NO 12; PP. 907-914; ABS. ENG; BIBL. 26 REF.Article

PHENOLPHTHALEIN-MONOPHOSPHAT ALS SUBSTRAT ZUR BESTIMMUNG DER SAUREN PROSTATAPHOSPHATASE: KRITISCHE ANMERKUNGEN. = EMPLOI DU MONOPHOSPHATE DE PHENOLPHTALEINE COMME SUBSTRAT POUR LE DOSAGE DE LA PHOSPHATASE ACIDE DE LA PROSTATE: ETUDE CRITIQUEGALLATI H.1977; J. CLIN. CHEM. CLIN. BIOCHEM.; GERM.; DA. 1977; VOL. 15; NO 6; PP. 323-328; ABS. ANGL.; BIBL. 9 REF.Article

BILDUNG UND REININGUNG DES OXIDOREDUCTASE-INHIBITORS AUS DEM NAD. = FORMATION ET PURIFICATION DE L'INHIBITEUR D'UNE OXYDOREDUCTASE A PARTIR DU NADGALLATI H.1976; Z. KLIN. CHEM. KLIN. BIOCHEM.; DTSCH.; DA. 1976; VOL. 14; NO 1; PP. 3-8; ABS. ANGL.; BIBL. 19 REF.Article

PEROXIDASE AUS MEERRETTICH: KINETISCHE STUDIEN SOWIE OPTIMIERUNG DER AKTIVITAETSBESTIMMUNG MIT DEN SUBSTRATEN H₂O₂ UND 2,2'-AZINO-DI-(3-ETHYL-BENZTHIAZOLINSULFONSAEURE-(6) (ABTS) = LA PEROXYDASE DU RAIFORT: ETUDE CINETIQUE ET DETERMINATION DES CONDITIONS OPTIMUM DE REACTION, AVEC LE PEROXYDE D'HYDROGENE ET L'AZINO-2,2'DI-(ETHYL-3 BENZTHIAZOLINE SULFONIQUE ACIDE-(6) (ABTS)GALLATI H.1979; J. CLIN. CHEM. CLIN. BIOCHEM.; DEU; DA. 1979; VOL. 17; NO 1; PP. 1-7; ABS. ENG; BIBL. 20 REF.Article

PERJODAT-BESTIMMUNG: EINFACHE, KOLORIMETRISCHE METHODE MIT HOHER EMPFINDLICHKEIT UND SELEKTIVITAET. = DOSAGE DU PERIODATE: METHODE COLORIMETRIQUE SIMPLE, DE SELECTIVITE ET SENSIBILITE ELEVEEGALLATI H.1978; ANAL. CHIM. ACTA; PAYS-BAS; DA. 1978; VOL. 96; NO 2; PP. 311-317; ABS. ANGL.; BIBL. 16 REF.Article

ENZYM-IMMUNOLOGISCHE TESTS: AKTIVITAETSBESTIMMUNG VON PEROXIDASE MIT HILFE DES "TRINDER-REAGENS". = TESTS IMMUNOENZYMATIQUES: ANALYSE DE LA PEROXYDASE A L'AIDE DU REACTIF DE TRINDERGALLATI H.1977; J. CLIN. CHEM. CLIN. BIOCHEM.; GERM.; DA. 1977; VOL. 15; NO 2; PP. 699-703; ABS. ANGL.; BIBL. 6 REF.Article

BLUTNACHWEIS IM STUHL. WESENTLICHE VERBESSERUNG DES GUAIAC-TESTS DURCH EINFACHE MODIFIKATION BEI DER TESTAUSFUEHRUNG = MISE EN EVIDENCE DE SANG DANS LES SELLES. AMELIORATION DU TEST EN GUAIAC PAR UNE MODIFICATION SIMPLE DE LA CONDUITE DU TESTGALLATI H.1978; MED. WELT; DEU; DA. 1978; VOL. 29; NO 49; PP. 1929-1932; BIBL. 9 REF.Article

PEROXIDASE AUS MEERRETTICH: REAGENS ZUM ABSTOPPEN DER KATALYTISCHEN UMSETZUNG DER SUBSTRATE H₂O₂ UND 2,2'-AZINO-DI(3-ETHYL-BENZTHIAZOLINSULFONSAEURE-(G) (ABTS) = PEROXYDASE DU RAIFORT. REACTIF POUR ARRETER LA CONVERSION CATALYTIQUE DES SUBSTRATS H₂O₂ ET AZINO-2,2' DI(ETHYL-3 BENZTHIAZOLINE SULFONIQUE ACIDE (ABTS)GALLATI H; BRODBECK H.1982; J. CLIN. CHEM. CLIN. BIOCHEM.; ISSN 0340-076X; DEU; DA. 1982; VOL. 20; NO 10; PP. 757-760; ABS. ENG; BIBL. 10 REF.Article

AKTIVIERUNG DER SAUREN PROSTATAPHOSPHATASE DURCH 1-PENTANOL. = ACTIVATION DE LA PHOSPHATASE ACIDE D'ORIGINE PROSTATIQUE PAR LE PENTANOL-1GALLATI H; ROTH M.1976; J. CLIN. CHEM. CLIN. BIOCHEM.; GERM.; DA. 1976; VOL. 14; NO 12; PP. 581-587; ABS. ANGL.; BIBL. 16 REF.Article

PEROXIDASE AUS MEERRETTICH: KINETISCHE STUDIEN UND OPTIMIERUNG DER AKTIVITAETSBESTIMMUNG MIT DEN SUBSTRATEN H₂O₂ UND O-PHENYLENDIAMIN = PEROXYDASE DU RAIPORT. ETUDE CINETIQUE ET OPTIMALISATION DU DOSAGE D'ACTIVITE AVEC LES SUBSTRATS H₂O₂ ET O-PHENYLENEDIAMINEGALLATI H; BRODBECK H.1982; J. CLIN. CHEM. CLIN. BIOCHEM.; ISSN 0340-076X; DEU; DA. 1982; VOL. 20; NO 4; PP. 221-225; ABS. ENG; BIBL. 6 REF.Article

Peroxidase aus Meerrettich: Kinetische Studien und Optimierung der Peroxidase-Aktivitätsbestimmung mit den Substraten H₂O₂ und 3,3',5,5'-Tetramethylbenzidin = La peroxydase de Raifort: études cinétiques et optimisation du dosage de l'enzyme à l'aide des substrats H₂O₂ et tétraméthyl 3,3',5,5' benzidine = Horseradish peroxidase: kinetic studies and optimization of the peroxidase activity determination with the substrates H₂O₂ and 3,3',5,5'-tetramethylbenzidineGALLATI, H; PRACHT, I.Journal of clinical chemistry and clinical biochemistry. 1985, Vol 23, Num 8, pp 453-460, issn 0340-076XArticle

Increased serum levels of soluble tumor necrosis factor a-receptors in patients undergoing partial liver resectionSCHRODER, J; GALLATI, H; KREMER, B et al.Hepato-gastroenterology. 1998, Vol 45, Num 23, pp 1807-1812, issn 0172-6390Article

Soluble tumour necrosis factor receptors p55 and p75 in the urine monitor disease activity and the efficacy of treatment of inflammatory bowel diseaseHADZISELIMOVIC, F; EMMONS, L. R; GALLATI, H et al.Gut. 1995, Vol 37, Num 2, pp 260-263, issn 0017-5749Article

Differential expression of PDGF A- and B-chain genes and production of AA and AB dimers by activated human blood monocytesALLAM, M; MARTINET, N; GALLATI, H et al.Biochimie (Paris). 1992, Vol 74, Num 12, pp 1097-1101, issn 0300-9084Article

Evaluation of a test system for measuring cytokine production in human whole blood cell culturesELASASSER-BEILE, U; VON KLEIST, S; GALLATI, H et al.Journal of immunological methods. 1991, Vol 139, Num 2, pp 191-195, issn 0022-1759, 5 p.Article

Recombinant human interferon alpha-2a: delivery to lymphoid tissue by selected modes of applicationSUPERSAXO, A; HEIN, W; GALLATI, H et al.Pharmaceutical research. 1988, Vol 5, Num 8, pp 472-476, issn 0724-8741Article

Animal pharmacokinetics of the tumor necrosis factor receptor-immunoglobulin fusion protein lenercept and their extrapolation to humansRICHTER, W. F; GALLATI, H; SCHILLER, C.-D et al.Drug metabolism and disposition. 1999, Vol 27, Num 1, pp 21-25, issn 0090-9556Article

Interleukin-6 : a sensitive parameter for the early diagnosis of neonatal bacterial infectionBUCK, C; BUNDSCHU, J; GALLATI, H et al.Pediatrics (Evanston). 1994, Vol 93, Num 1, pp 54-58, issn 0031-4005Article

Interleukin-6, gamma interferon, and tumor necrosis factor receptors in typhoid fever related to outcome of antimicrobial therapyBUTLER, T; MAY HO; GOPAL ACHARYA et al.Antimicrobial agents and chemotherapy. 1993, Vol 37, Num 11, pp 2418-2421, issn 0066-4804Article

Improvement of impaired mitogen-induced interferon-gamma release of peripheral blood mononuclear cells derived from tumor patients by Factor AF2BAIER, J. E; NEUMANN, H. A; GALLATI, H et al.Research in experimental medicine. 1991, Vol 191, Num 4, pp 281-289, issn 0300-9130Article

Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virusARNOLD, R; HUMBERT, B; WERCHAU, H et al.Immunology (Oxford). 1994, Vol 82, Num 1, pp 126-133, issn 0019-2805Article

Treatment of systemic mastocytosis with interferon-γ : failure after appearance of anti-IFN-γ antibodiesFIEHN, C; PRÜMMER, O; GALLATI, H et al.European journal of clinical investigation. 1995, Vol 25, Num 8, pp 615-618, issn 0014-2972Article

Serum levels of cytokines and soluble cytokine receptors in patients with metastatic renal cell carcinoma or malignant melanoma receiving Il-2/interferon-α combination therapyFOSSA, S. D; AAMDAL, S; NAUME, B et al.Acta oncologica (Stockholm). 1995, Vol 34, Num 5, pp 599-603, issn 0284-186XConference Paper

Evaluation of cytokine levels in whole cell cultures of patients with gynaecological tumors as diagnostic parametersELSASSER-BEILE, U; VON KLEIST, S; GALLATI, H et al.Anticancer research. 1991, Vol 11, Num 3, pp 1093-1095, issn 0250-7005Article

Untersuchung zur Zytokin-Produktion bei gynäkologischen Karzinomen = Study on cytokine production in gynaecological cancerFRIESE, K; WESCH, D; GALLATI, H et al.Geburtshilfe und Frauenheilkunde. 1991, Vol 51, Num 3, pp 178-181, issn 0016-5751Article